SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BioPlus Acquisition Corp. (BIOSW) 当前追踪市盈率 (P/E) 为 0.2. 追踪盈利收益率为 625.00%.
本页证实的标准:
- VALUE (100/100, 通过) — 市盈率低于市场平均水平 (0.2); 盈利收益率超过债券收益率 (625.00%).
- 追踪盈利收益率 625.00% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
SharesGrow 综合评分： 55/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
75/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BIOSW
估值倍数
P/E (TTM)0.2
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.01
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率625.00%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2011 |
$-0.60 |
$0.00 |
$-33.11M |
- |
| 2012 |
$-0.15 |
$662.6M |
$-8.4M |
-1.3% |
| 2013 |
$-0.83 |
$842.2M |
$-53.6M |
-6.4% |
| 2014 |
$-2.09 |
$984.1M |
$-143.4M |
-14.6% |
| 2015 |
$-4.42 |
$982.2M |
$-303.5M |
-30.9% |
| 2016 |
$-0.37 |
$935.6M |
$-34.4M |
-3.7% |
| 2017 |
$-1.06 |
$817.2M |
$-131M |
-16% |
| 2018 |
$-0.40 |
$708.9M |
$-51.6M |
-7.3% |
| 2021 |
$-0.02 |
$0.00 |
$-153.00 |
- |
| 2022 |
$0.01 |
$0.00 |
$5.16M |
- |
